Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
10.40
-0.04 (-0.41%)
Apr 29, 2026, 2:48 PM EDT - Market open
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.65 billion as of April 29, 2026. Its market cap has decreased by -35.52% in one year.
Market Cap
3.65B
Enterprise Value
4.00B
1-Year Change
-35.52%
Ranking
Category
Stock Price
$10.40
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.65B, an increase of 3,064.98%. That is a compound annual growth rate of 50.45%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 3.96B |
| Veradermics | 3.95B |
| ACADIA Pharmaceuticals | 3.85B |
| Travere Therapeutics | 3.83B |
| Viking Therapeutics | 3.80B |
| Oruka Therapeutics | 3.74B |
| Catalyst Pharmaceuticals | 3.59B |
| Tango Therapeutics | 3.55B |